GUARDaHEART and Starbucks® Collaborate for Impactful Event to Help Homeless Families
Irvine, CA (PRWEB) May 06, 2015 -- The GUARDaHEART Foundation was proud to work alongside Starbucks at the Starbucks Community Resource Exchange with the mission of providing basic living essentials and health services to local Orange County families in need on Thursday, April 30th.
Through its partnership with the PULS Cardiac Test, an advanced blood test for the early-detection and diagnosis of heart disease, GUARDaHEART was able to provide potentially life changing advanced medical testing to homeless individuals and families.
“Heart Disease is a tremendous health risk that effects all of us, but it is mostly preventable and even reversible,” said Gina McLane, of GUARDaHEART. “We are proud that so many people took advantage of the PULS Cardiac Test and other medically necessary testing that we were able to provide, so that they too can be empowered with important information about their heart health.”
“I am very impressed with the way that [GUARDaHEART] embraced every person they interacted with at the Starbucks Community Resource Exchange to make a positive difference,” said Blythe Persing, District Manager for Starbucks.
Other organizations that worked with GUARDaHEART to make the event a success included Tosi Health, Marisa Kenson for MK Collab, Cookie Connection, and Tanaka Farms.
About GUARDaHEART
GUARDaHEART is a 501(c)(3) nonprofit dedicated to fighting heart disease with the mission: “LEARN. DETECT. PREVENT.” GUARDaHEART works with strategic partners, healthcare providers, and other non-profit organizations to promote awareness through education and risk detection tools, to ultimately empower preventative action and reduce the risk of heart disease worldwide.
About the PULS Cardiac TestTM
The PULS (Protein Unstable Lesion Signature) Cardiac Test analyzes clinically validated proteins directly related to the biological processes underlying Unstable Cardiac Lesion formation and CHD development. The research behind the test found that the use of nine biomarkers and established clinical risk factors correlated with the underlying formation of unstable cardiac lesions, and proved to significantly improve identification of at-risk patients frequently missed by current methods. Results demonstrated that the novel protein-biomarker and clinical risk factor algorithm identified patients who are at risk of an acute coronary event. Acute Coronary Syndrome (ACS) is the main cause of coronary artery disease mortality. For more information, visit http://www.PULStest.com.
Public Relations, PULS Cardiac Test, http://pulstest.com/, +1 858 354 4526, [email protected]
Share this article